AB

Abdullo Bobonazarov

Active Director Director DIN 11197488
DIN 11197488 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Abdullo Bobonazarov

Data last updated:

Abdullo Bobonazarov is a Director at Spey Medical Private Limited (since 2025). The company operates in Pharma. Spey Medical Private Limited reported revenue of ₹24.33 Cr (FY 2025).

DIN 11197488
Primary Designation Director
Industry Pharma
First Appointment 16 Jul 2025
Oldest Company Age 15 yrs
Largest company Spey Medical Private Limited · ₹24.33 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Spey Medical Private Limited U51909HR2011PTC127343
Director16 Jul 20252011₹24.33 Cr (FY 2025)Active

Board colleagues of Abdullo Bobonazarov

Directorship timeline

Open interactive timeline →
Spey Medical Private Limited
Premium access

Shareholding and investment profile for Abdullo Bobonazarov

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdullo Bobonazarov

Abdullo Bobonazarov currently holds 1 directorship: Spey Medical Private Limited (Director, since 16 Jul 2025, revenue ₹24.33 Cr (FY 2025)).

Abdullo Bobonazarov was first appointed on 16 Jul 2025 as Director at Spey Medical Private Limited.

The current boards of Abdullo Bobonazarov's companies include Ilkhomzhon Mirzoev (Spey Medical Private Limited), Sadullo Abdulloev (Spey Medical Private Limited), Zafarkhon Mirzoev (Spey Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available